PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$24.44
-1.05 (-4.12%)
Open$26.90
Previous Close$25.49
Day High$27.13
Day Low$23.47
52W High$27.64
52W Low$18.80
Volume—
Avg Volume735.4K
Market Cap929.88M
P/E Ratio180.98
EPS$0.13
SectorPharmaceuticals
Analyst Ratings
Buy
13 analysts
Price Target
-7.1% upside
Current
$24.44
$24.44
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 613.61M | 596.31M | 216.59M |
| Net Income | 5.94M | 5.20M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 58.18M | 53.72M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |